Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
science, at the interface between chemistry, biology, and health. Its research focuses in particular on the synthesis and design of bioactive peptides, foldamers, protein–peptide interactions, and
-
Laboratory of Oceanography of Villefranche | Villefranche sur Mer, Provence Alpes Cote d Azur | France | 18 days ago
: Research assistant Duration: 24 months, spring 2027 Localization: Villefranche sur mer, France Scientific discipline: Marine Volatile Organic Compounds Technical expertise required: Mass spectrometry
-
, the proteolytic mechanisms involved in dental pulp inflammation, particularly in various 2D/3D models. The postdoctoral researcher will produce bioactive protein fragments and characterise their roles in dental
-
molecules and materials. The resulting compounds will be evaluated for the hydrogen evolution reaction using electroanalytical and analytical techniques (micro-GC, etc.). Main activities : Develop and
-
to interact. Using these compounds, we aim to describe the covalent interactions between f-block elements, including interactions between f orbitals of Phi symmetry, leading to the emergence of a Phi-type metal
-
of chemistry and synthetic chemistry to the synthesis of compounds based on structure activity relationship (SAR) studies. Maintaining host cell cultures and parasite life cycles, including genetically modified
-
strong interest/background in multistep synthesis of complex bioactive molecules. Website for additional job details https://emploi.cnrs.fr/Offres/CDD/UMR5255-PHIPEI-003/Default.aspx Work Location(s
-
aim to determine the mechanisms of action of the compounds and evaluate restoration of immunity leading to functional cures. The project will investigate virological and immunological parameters using
-
Normandy (Caesar Program) and aims to explore innovative mixed-anion compounds with complex crystal structures for efficient thermal energy conversion. Research Project: Thermoelectric materials directly
-
cells. Compounds identified through a pharmacological screening approach represent promising therapeutic leads, including in models of bortezomib-resistant cell lines. The project combines a fundamental